GLP-1 Agonists: Heart & Kidney Benefits in Type 1 Diabetes
GLP-1 Receptor Agonists Show Promise in Protecting Type 1 Diabetes Patients from Cardiovascular and Kidney Complications Groundbreaking research indicates a significant benefit for individuals living with type 1 diabetes. A large-scale study, analyzing health records of over 174,000 patients, suggests that initiating treatment with GLP-1 receptor agonists (GLP-1RAs) is linked to a reduced risk of … Read more